ORALS
_______________
PRODUCT NAME | FORM | STRENGTH | THERAPEUTIC AREA | STATUS |
---|---|---|---|---|
APIXABAN | Film-coated tablets | 2.5 and 5 mg | Antithrombotic agent | Available EU CTD |
CLOPIDOGREL BESILATE | Film-coated Tablets | 75 mg/tab. | Anti-thrombotic | Available EU CTD |
DEXAMETHASONE | Soluble Tablets | 2 mg/tab. | Glucocorticoid Therapy | Available EU CTD |
DEXAMETHASONE | Soluble Tablets | 4 mg/tab | Glucocorticoid Therapy | Available EU CTD |
DEXAMETHASONE | Soluble Tablets | 8 mg/tab | Glucocorticoid Therapy | Available EU CTD |
DEXAMETHASONE | Soluble Tablets | 10 mg/tab | Glucocorticoid Therapy | Available EU CTD |
DEXAMETHASONE | Soluble Tablets | 20 mg/tab | Glucocorticoid Therapy | Available EU CTD |
DUTASTERIDE | Soft Gel Capsules | 0.5 mg/caps | Benign Prostatic Hyperplasia | Available EU CTD |
ELETRIPTAN | Film-coated Tablets | 40 mg/tab | Migraine Treatment | Available EU CTD |
ELETRIPTAN | Film-coated Tablets | 20 mg/tab | Migraine Treatment | Available EU CTD |
ELETRIPTAN | Film-coated Tablets | 80 mg/tab | Migraine Treatment | Available EU CTD |
EZETIMIBE | Tablets | 10 mg/tab | Primary Hypercholesterolaemia | Available EU CTD |
PARICALCITOL | Soft Gel Capsules | 1 mcg/cap | Secondary Hyperparathyroidism | Available EU CTD |
PARICALCITOL | Soft Gel Capsules | 2 mcg/cap | Secondary Hyperparathyroidism | Available EU CTD |
PARICALCITOL | Soft Gel Capsules | 4 mcg/cap | Secondary Hyperparathyroidism | Available EU CTD |
PARICALCITOL | Sol. Inj. 1ml vial or amp | 2 mcg/ml | Secondary Hyperparathyroidism | Available EU CTD |
PARICALCITOL | Sol. Inj. 1ml vial or amp | 5 mcg/ml | Secondary Hyperparathyroidism | Available EU CTD |
PARICALCITOL | Sol. Inj. 2ml vial or amp | 5 mcg/ml | Secondary Hyperparathyroidism | Available EU CTD |
ROSUVASTATIN CALCIUM | Film-coated Tablets | 5 mg/tab | Hypercholesterolaemia &Prevention of Cardiovascular Events | Available EU CTD |
ROSUVASTATIN CALCIUM | Film-coated Tablets | 10 mg/tab | Hypercholesterolaemia &Prevention of Cardiovascular Events | Available EU CTD |
ROSUVASTATIN CALCIUM | Film-coated Tablets | 20 mg/tab | Hypercholesterolaemia &Prevention of Cardiovascular Events | Available EU CTD |
TICAGRELOR | Film-coated tablets | 60 and 90 mg | Antithrombotic agent | Available EU CTD |
ZOLEDRONIC ACID | Conc. Sol. Inf. 5 ml vial | 4 mg/5 ml | Skeletal Related Events in Advanced Malignancies & Tumour-Induced ypercalcaemia | Available EU CTD |
OPTHALMICS
INJECTABLES
ORALS
OTHERS